Spectrophotometers Revolutionize Drug Quality Control
Baca dalam 60 detik
- Spectrophotometers use light absorption to identify chemical signatures, catching substandard ingredients before they reach production lines.
- This non-destructive method cuts testing time from hours to minutes while maintaining 99.
- 9% accuracy.
Spectrophotometers use light absorption to identify chemical signatures, catching substandard ingredients before they reach production lines. This non-destructive method cuts testing time from hours to minutes while maintaining 99. 9% accuracy.
The push for precision comes as global drug counterfeiting costs the industry $200 billion annually. Spectrophotometers can differentiate genuine APIs from look-alike fillers, a critical capability for supply chain security. Regulators now recommend this technology for high-risk medications like antibiotics and opioids.
Market leaders like Thermo Fisher and Agilent are driving innovation with portable models for on-site testing. These devices enable real-time quality checks at manufacturing hubs, reducing dependency on central labs. The shift promises to cut quality-related recalls by 25% within two years.
Power Move: Spectrophotometers aren't just tools—they're gatekeepers for drug integrity. Expect regulators to mandate their use for high-risk drugs by 2026, reshaping quality protocols globally. Early adopters will dominate market trust and regulatory compliance.
This article was edited with AI assistance for readability. Read original here.
